Amundi’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Buy |
567,615
+161,936
| +40% | +$9.26M | 0.01% | 632 |
|
|
2025
Q1 | $27.4M | Buy |
405,679
+6,441
| +2% | +$435K | 0.01% | 656 |
|
|
2024
Q4 | $27.3M | Buy |
399,238
+88,247
| +28% | +$6.03M | 0.01% | 666 |
|
|
2024
Q3 | $21.4M | Sell |
310,991
-36,006
| -10% | -$2.47M | 0.01% | 703 |
|
|
2024
Q2 | $28.1M | Sell |
346,997
-97,123
| -22% | -$7.86M | 0.01% | 641 |
|
|
2024
Q1 | $40M | Buy |
444,120
+68,910
| +18% | +$6.21M | 0.02% | 567 |
|
|
2023
Q4 | $36.1M | Sell |
375,210
-397,780
| -51% | -$38.2M | 0.02% | 598 |
|
|
2023
Q3 | $66.7M | Buy |
772,990
+341,737
| +79% | +$29.5M | 0.03% | 441 |
|
|
2023
Q2 | $37M | Sell |
431,253
-736,068
| -63% | -$63.2M | 0.02% | 579 |
|
|
2023
Q1 | $113M | Sell |
1,167,321
-506,372
| -30% | -$48.9M | 0.06% | 326 |
|
|
2022
Q4 | $186M | Sell |
1,673,693
-70,739
| -4% | -$7.86M | 0.1% | 227 |
|
|
2022
Q3 | $156M | Buy |
1,744,432
+1,448,878
| +490% | +$130M | 0.09% | 241 |
|
|
2022
Q2 | $25.6M | Buy |
295,554
+34,039
| +13% | +$2.95M | 0.02% | 576 |
|
|
2022
Q1 | $21.8M | Buy |
261,515
+111,623
| +74% | +$9.3M | 0.01% | 638 |
|
|
2021
Q4 | $13.2M | Buy |
149,892
+3,984
| +3% | +$351K | 0.01% | 776 |
|
|
2021
Q3 | $11.3M | Buy |
145,908
+7,933
| +6% | +$613K | 0.01% | 810 |
|
|
2021
Q2 | $11.5M | Buy |
+137,975
| New | +$11.5M | 0.01% | 801 |
|